Zymergen might be better run, it certainly helps not being in debt and not have shareholders; I don't know about Twist. But Zymergen is playing catch up and is aiming for a different and smaller market than Amyris. And they don't have the technology, or more importantly, the intellectual property, of Amyris. But I don't invest in any company because of one person. I guess some people do but I've never thought that made any sense, just a difference in opinion I guess.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.